Salivary production in Parkinson's disease

被引:118
作者
Proulx, M
de Courval, FP
Wiseman, MA
Panisset, M
机构
[1] McGill Univ, Movement Disorders Clin, McGill Ctr Studies Aging, Verdun, PQ H4H 1R3, Canada
[2] Univ Montreal, Fac Med Dent, Montreal, PQ H3C 3J7, Canada
[3] McGill Univ, Fac Dent, Montreal, PQ H3A 2T5, Canada
关键词
Parkinson's disease; drooling; dysphagia; hypersialorrhea; levodopa;
D O I
10.1002/mds.20189
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Hypersialorrhea is a common phenomenon in Parkinson disease (PD). The objective of this study was to determine whether patients with PD had an abnormally increased production of saliva and whether the production of saliva could be associated to factors related to either the disease characteristics or to its treatment. A total of 83 patients with PD and 55 control subjects participated in this study. Because of the age difference between the two groups, comparisons were made on a +/-2-year age-matched sample of 44 PD patients and 44 control subjects. PD patients produced significantly less saliva than control subjects. Correlations were obtained with the 83 PD patients between unstimulated salivary flow and patients characteristics. When controlling for age, sex, and Hoehn and Yahr scale, decreased production of saliva correlated significantly with the dose of levodopa and the symptoms of xerostomia. When controlling for medications, there was no relationship between the production of saliva and the evolution of the disease. This study shows that patients with PD produce less saliva than normal. Factors influencing the production of saliva include the use of levodopa and female gender. Our results may have implications for the treatment of drooling in PD. (C) 2004 Movement Disorder Society
引用
收藏
页码:204 / 207
页数:4
相关论文
共 27 条
  • [1] Bagheri H, 1999, CLIN NEUROPHARMACOL, V22, P213
  • [2] SALIVARY SYMPTOMS IN PARKINSON DISEASE
    BATESON, MC
    GIBBERD, FB
    WILSON, RSE
    [J]. ARCHIVES OF NEUROLOGY, 1973, 29 (04) : 274 - 275
  • [3] EADIE MJ, 1965, AUSTRALAS ANN MED, V14, P13
  • [4] GASTROINTESTINAL SYMPTOMS IN PARKINSONS-DISEASE
    EDWARDS, LL
    PFEIFFER, RF
    QUIGLEY, EMM
    HOFMAN, R
    BALLUFF, M
    [J]. MOVEMENT DISORDERS, 1991, 6 (02) : 151 - 156
  • [5] GASTROINTESTINAL DYSFUNCTION IN PARKINSONS-DISEASE - FREQUENCY AND PATHOPHYSIOLOGY
    EDWARDS, LL
    QUIGLEY, EMM
    PFEIFFER, RF
    [J]. NEUROLOGY, 1992, 42 (04) : 726 - 732
  • [6] Diagnostic criteria for Parkinson disease
    Gelb, DJ
    Oliver, E
    Gilman, S
    [J]. ARCHIVES OF NEUROLOGY, 1999, 56 (01) : 33 - 39
  • [7] Xerostomia - Etiology, recognition and treatment
    Guggenheimer, J
    Moore, PA
    [J]. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2003, 134 (01) : 61 - 69
  • [8] JOHNSTON BT, 1995, AM J GASTROENTEROL, V90, P1741
  • [9] Jost WH, 1999, MOVEMENT DISORD, V14, P1057, DOI 10.1002/1531-8257(199911)14:6<1057::AID-MDS1033>3.0.CO
  • [10] 2-4